AbbVie (ABBV) February weekly 165 straddle into quarter results
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $242.58 +3.27%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +26.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +26.6%
Join SI Premium – FREE
AbbVie (NYSE: ABBV) February weekly 165 straddle priced for a move of 3.5% into the expected release of quarter results before the bell on February 2.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
- FedEx Freight (FDXF) call put ratio 1 call to 1.7 puts into quarter results
- Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patie
Create E-mail Alert Related Categories
Option EPS Action, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
